Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 1.79 B3.23 B3.23 B1.65 B2.96 B3.14 B 10.97 B Non-Operating Income, Total 14 M15 M16 M14 M3 M1 M 34 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 14 M15 M16 M14 M3 M1 M 34 M Unusual income/expense —————— — Pretax income 1.68 B3.12 B3.08 B1.51 B2.86 B2.93 B 10.38 B Equity in earnings 143 M148 M107 M112 M158 M87 M 464 M Taxes 606 M740 M700 M396 M676 M631 M 2.4 B Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.08 B2.38 B2.38 B1.12 B2.18 B2.3 B 7.97 B Discontinued operations —————— — Net income 1.08 B2.38 B2.38 B1.12 B2.18 B2.3 B 7.97 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.07 B2.37 B2.37 B1.11 B2.18 B2.29 B 7.95 B Basic earnings per share (Basic EPS) 0.631.411.410.671.31.37 4.75 Diluted earnings per share (Diluted EPS) 0.631.411.410.671.31.37 4.75 Average basic shares outstanding 1.69 B1.68 B1.68 B1.68 B1.67 B1.67 B — Diluted shares outstanding 1.69 B1.68 B1.68 B1.68 B1.67 B1.67 B — EBITDA 2.4 B3.88 B3.84 B2.4 B3.54 B3.83 B 13.61 B EBIT 2.32 B3.81 B3.77 B2.34 B3.48 B3.78 B 13.37 B Cost of revenue 2.01 B2.25 B2.26 B2.21 B1.92 B2.29 B 8.69 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 71 M71 M70 M54 M56 M56 M 236 M